Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Press Release from Mosaic, 14 Dec 2020
Reply New Message
Back To Forum List View
Press Release from Mosaic, 14 Dec 2020

Willy Nilly
Dec 14, 2020 10:17AM
Re: Press Release from Mosaic, 14 Dec 2020

potofgold
Dec 14, 2020 10:50AM
Re: Press Release from Mosaic, 14 Dec 2020

potofgold
Dec 14, 2020 11:18AM
Re: Press Release from Mosaic, 14 Dec 2020

errolofdanvers
Dec 17, 2020 12:03AM

I don't think dilution is a major concern right now. They receive grants and grants they are not dilutive...

If you want to pick up shares, my guess is $2.50 to $3.00 is a low entry point...

Re: Press Release from Mosaic, 14 Dec 2020

medtech7309
Dec 30, 2020 10:40AM
Re: Press Release from Mosaic, 14 Dec 2020

herrid119
Dec 30, 2020 02:41PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply